司美格鲁肽三季度营收超203亿美元 | 诺和诺德财报

医药时间
06 Nov 2024

2024年11月6日,诺和诺德发布三季度财报:2024年前三季度,诺和诺德销售额以丹麦克朗计算增长了23%,达到2047亿丹麦克朗(294.6亿美元);营业利润按丹麦克朗计算增长18%,达到727.58亿丹麦克朗(104.7亿美元)。以丹麦克朗计算,国际业务的销售额增长了13%,其中中国业务的销售额以丹麦克朗计算增长了8%。值得一提的是,诺和诺德糖尿病和肥胖护理部门的销售额以丹麦克朗计算增长25%...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10